FDA orders safety studies for some asthma drugs

2011-04-18T11:00:53Z

WASHINGTON/NEW YORK (Reuters) - U.S. health regulators have ordered drugmakers to conduct clinical trials involving a total of 53,000 patients to test the safety of a controversial class of inhaled asthma drugs that are already on the market.

The trials are being required to demonstrate the safety of medicines known as long-acting beta-agonists (LABAs) when used in combination with inhaled s...

Ventolin Coupons

2010-11-30T12:56:56Z

...

Glaxo's Asthma Drug Looks Increasingly Bullet-Proof

2010-10-25T11:23:48Z

...

Experts question study's asthma drug safety claim

2010-04-16T10:44:11Z

NEW YORK (Reuters Health) - An author of a new industry-funded study on the safety of a commonly prescribed type of inhaled asthma drug says the findings should be "reassuring" to patients who use them. However, two researchers who have published studies of their own on the medications disagree.

The medications involved are called long-acting beta agonists, and they include

GSK and Theravance Announce Positive Phase 2b Results for Once-daily Fluticasone Furoate in the Treatment of Asthma

2010-10-23T19:22:07Z

...

UPDATE 2-US FDA panel: Two asthma drugs risky but Advair OK

2010-10-21T09:46:37Z

...

Childhood Paracetamol Use Linked to Later Asthma Symptoms

2010-10-23T19:00:28Z

...

Asthma Drug Warning Strengthened

2010-10-14T08:04:34Z

...

GlaxoSmithKline

2010-10-14T07:52:33Z

...

Glaxo Drug Warning Strengthened

2010-10-14T07:47:52Z

...

BRITAIN GLAXOSMITHKLINE

2010-04-15T03:13:25Z

A sign for British pharmaceuticals firm GlaxoSmithKline is seen on its offices, in London, Monday, April 20, 2009. British drug maker GlaxoSmithKline PLC said Monday it will pay $2.9 billion to buy American dermatology business Stiefel Laboratories Inc. GlaxoSmithKline will also assu...

The latest in Glaxosmithkline Plc